LifeScience Biologics
Thermo Fisher Scientific Accelerates IND Timelines With Enhanced Platform and High-Yield CHO K-1 Cell Line
Enhanced platform technology and the addition of a robust, high-quality CHO K-1 cell line decreases lead time to Investigational New Drug (IND) Thermo Fis...
April 29, 2025 | News
Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership
Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...
April 28, 2025 | News
Keymed Biosciences Advances CDH17-Targeted ADC CM518D1 Into Phase I/II Trials for Solid Tumors in China
Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) develop...
April 28, 2025 | News
Primo Biotechnology Secures PIC/S GMP and GDP Certifications, Strengthening Global Position in Nuclear Medicine
Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed inspection by Taiwan Food and Dr...
April 25, 2025 | News
Lotte Biologics Seals First ADC Manufacturing Deal to Launch Full-Scale US Production
Lotte Biologics has announced the signing of its first official contract manufacturing agreement at its newly expanded antibody-drug conjugate (ADC) produc...
April 25, 2025 | News
Beckman Coulter Launches OptiMATE Gradient Maker to Speed Up Ultracentrifugation Workflows
Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient...
April 24, 2025 | News
Gene Solutions and Element Biosciences Forge Multiomics Collaboration to Expand Access to Genetic Testing Across Asia and Beyond
Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing acc...
April 23, 2025 | News
Rona Therapeutics Secures IND Approval in China for siRNA-Based Hypertension Therapy RN1871
Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for&...
April 22, 2025 | News
GC Cell Secures Exclusive Rights to DAAN Biotherapeutics’ Tumor Antigen-Specific Antibody for CAR-T and CAR-NK Therapies
DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusi...
April 22, 2025 | News
WuXi Biologics Achieves Asia’s First Commercial PPQ Milestone with 3 x 5,000L Single-Use Bioreactors
- The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,0...
April 21, 2025 | News
Earendil Labs and Sanofi Sign $1.72B Licensing Deal for AI-Discovered Bispecific Antibodies Targeting Autoimmune and Inflammatory Bowel Diseases
Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and Sanofi announced that they have entered...
April 18, 2025 | News
VelaVigo Bio Signs $440M Global Licensing Deal with Ollin Biosciences for First-in-Class Bispecific Antibody VBS-102
VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specif...
April 18, 2025 | News
TGA Approves IFINWIL® for High-Risk Neuroblastoma Treatment in Australia
Norgine is pleased to announce that the Australian Therapeutic Goods Administration (TGA) has approved the registration of IFINWIL® (eflornit...
April 17, 2025 | Regulatory
Atmo Biosciences Secures Full Ownership of Core IP for Ingestible Gas-Sensing Capsule
Atmo secures full ownership of core IP for its ingestible gas-sensing capsule • RMIT University transfers all patents and IP in exchange for an eq...
April 15, 2025 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
